California Public Employees Retirement System Purchases 32,002 Shares of Perrigo Company plc (NYSE:PRGO)

California Public Employees Retirement System grew its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 4.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 692,916 shares of the company's stock after buying an additional 32,002 shares during the quarter. California Public Employees Retirement System owned approximately 0.51% of Perrigo worth $22,298,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PRGO. Patriot Financial Group Insurance Agency LLC lifted its holdings in shares of Perrigo by 4.1% during the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 9,627 shares of the company's stock worth $310,000 after purchasing an additional 380 shares during the period. Blue Trust Inc. lifted its holdings in shares of Perrigo by 34.5% during the fourth quarter. Blue Trust Inc. now owns 1,556 shares of the company's stock worth $50,000 after purchasing an additional 399 shares during the period. Xponance Inc. lifted its holdings in shares of Perrigo by 2.1% during the fourth quarter. Xponance Inc. now owns 20,153 shares of the company's stock worth $649,000 after purchasing an additional 410 shares during the period. Signaturefd LLC lifted its holdings in shares of Perrigo by 25.6% during the fourth quarter. Signaturefd LLC now owns 2,240 shares of the company's stock worth $72,000 after purchasing an additional 457 shares during the period. Finally, Fifth Third Bancorp lifted its holdings in shares of Perrigo by 39.5% during the third quarter. Fifth Third Bancorp now owns 1,714 shares of the company's stock worth $55,000 after purchasing an additional 485 shares during the period. Institutional investors own 95.91% of the company's stock.

Insider Transactions at Perrigo

In other news, EVP Alison Ives acquired 2,490 shares of Perrigo stock in a transaction on Tuesday, March 5th. The stock was acquired at an average cost of $27.26 per share, with a total value of $67,877.40. Following the transaction, the executive vice president now owns 16,122 shares of the company's stock, valued at approximately $439,485.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Patrick Lockwood-Taylor acquired 9,500 shares of Perrigo stock in a transaction on Thursday, February 29th. The stock was acquired at an average cost of $26.54 per share, with a total value of $252,130.00. Following the transaction, the chief executive officer now owns 20,500 shares of the company's stock, valued at approximately $544,070. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Alison Ives bought 2,490 shares of Perrigo stock in a transaction dated Tuesday, March 5th. The shares were bought at an average cost of $27.26 per share, with a total value of $67,877.40. Following the completion of the transaction, the executive vice president now directly owns 16,122 shares in the company, valued at $439,485.72. The disclosure for this purchase can be found here. Insiders acquired a total of 17,990 shares of company stock valued at $475,227 over the last three months. Corporate insiders own 0.40% of the company's stock.

Analyst Upgrades and Downgrades

PRGO has been the topic of a number of recent research reports. StockNews.com upgraded shares of Perrigo from a "hold" rating to a "buy" rating in a report on Wednesday, April 3rd. Piper Sandler boosted their target price on shares of Perrigo from $35.00 to $39.00 and gave the company an "overweight" rating in a report on Monday, April 8th. Canaccord Genuity Group restated a "buy" rating and issued a $42.00 target price on shares of Perrigo in a report on Friday, April 12th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Perrigo from $48.00 to $41.00 and set an "overweight" rating on the stock in a report on Wednesday, February 28th.

Perrigo Stock Up 2.7 %

Shares of NYSE PRGO traded up $0.86 during trading on Monday, hitting $32.80. 868,960 shares of the company traded hands, compared to its average volume of 1,801,352. The business's fifty day moving average is $30.54 and its 200 day moving average is $30.82. Perrigo Company plc has a fifty-two week low of $25.77 and a fifty-two week high of $40.28. The firm has a market capitalization of $4.45 billion, a price-to-earnings ratio of -328.00 and a beta of 0.64. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.79.

Perrigo (NYSE:PRGO - Get Free Report) last posted its earnings results on Tuesday, February 27th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.83 by $0.03. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a negative net margin of 0.27% and a positive return on equity of 7.34%. The firm's revenue for the quarter was up .1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.75 earnings per share. Equities research analysts predict that Perrigo Company plc will post 2.55 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were given a dividend of $0.276 per share. The ex-dividend date was Thursday, March 7th. This is an increase from Perrigo's previous quarterly dividend of $0.27. This represents a $1.10 annualized dividend and a dividend yield of 3.37%. Perrigo's payout ratio is presently -1,100.00%.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.